Form D · Biotechnology
LUX BIOSCIENCES INC
Jersey City, NJ · CIK 0001366282
Offering snapshot reported Mar 6, 2012 · SEC filing
- Reported sold
- $16M Offering amount: $17.1M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 23, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 6, 2012 | Initial | $16,000,000 | No comparison | 8 | SEC filing |
| Dec 12, 2011 | Initial | $4,000,000 | No comparison | 10 | SEC filing |
| Jul 14, 2011 | Initial | $6,000,000 | No comparison | 10 | SEC filing |
| Mar 18, 2011 | Initial | $3,000,000 | No comparison | 10 | SEC filing |
| Dec 20, 2010 | Initial | $5,000,000 | No comparison | 10 | SEC filing |
| Oct 30, 2009 | Initial | $37,940,274 | No comparison | 10 | SEC filing |
| Jun 16, 2009 | Initial | $9,200,000 | No comparison | 10 | SEC filing |
| Nov 20, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 7, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-174381
Source: Form D, filed Mar 6, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eddy Anglade | Executive |
| A. Clarke Atwell | Executive |
| Axel Bolte | Director |
| Paul Chaney | Director |
| Thomas Dyrberg | Director |
| George Eldridge | Executive |
| Lutz Giebel | Director |
| Ulrich M. Grau | Director, Executive |
| David Guyer | Director |
| Dean Mitchell | Director |
| David Schnell | Director |
| Brett Skolnik | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Harborside Financial Center Plaza 10 14 Th Floor
Jersey City, NJ, 07302
Jersey City, NJ, 07302